肝癌破裂出血规范化治疗探讨

摘要/Abstract

中图分类号:

R735.7

叶枫, 马迪, 陈拥军. 肝癌破裂出血规范化治疗探讨[J]. 外科理论与实践, 2020, 25(01): 1-5.

YE Feng, MA Di, CHEN Yongjun. Research on standardized treatment of spontaneous rupture of hepatocellular carcinoma[J]. Journal of Surgery Concepts & Practice, 2020, 25(01): 1-5.

图/表1

参考文献35

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2]	郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19-28.
[3]	Sahu SK, Chawla YK, Dhiman RK, et al. Rupture of hepatocellular carcinoma: a review of literature[J]. J Clin Exp Hepatol, 2019, 9(2):245-256.
[4]	Zhu Q, Qiao GL, Xu C, et al. Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study[J]. Cancer Manag Res, 2017, 9:525-537.
[5]	Schwarz L, Bubenheim M, Zemour J, et al. Bleeding recurrence and mortality following interventional management of spontaneous HCC rupture: results of a multicenter European study[J]. World J Surg, 2018, 42(1):225-232. doi:10.1007/s00268-017-4163-8pmid:28799103
[6]	Zhong F, Cheng XS, He K, et al. Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study[J]. Springerplus, 2016, 5(1):1101. doi:10.1186/s40064-016-2762-8pmid:27468402
[7]	Sada H, Ohira M, Kobayashi T, et al. An analysis of surgical treatment for the spontaneous rupture of hepatocellular carcinoma[J]. Dig Surg, 2016, 33(1):43-50.
[8]	Li J, Huang L, Liu CF, et al. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: A case-control study[J]. World J Gastroenterol, 2014, 20(27):9121-9127.
[9]	Sun P, Song Z, Hu Q, et al. Rupture of hepatocellular carcinoma following transarterial embolization/chemoembolization: two cases report and systematic review[J]. Chin Ger J Clin Oncol, 2013, 12(2):76-82.
[10]	Zhu LX, Geng XP, Fan ST. Spontaneous rupture of hepatocellular carcinoma and vascular injury[J]. J Hepatobi-liary Surg, 2001, 136(6):682-687.
[11]	Zhu LX, Liu Y, Fan ST. Ultrastructural study of the vascular endothelium of patients with spontaneous rupture of hepatocellular carcinoma[J]. Asian J Surg, 2002, 25(2):157-162. pmid:12376238
[12]	Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma: A systematic review[J]. Arch Surg, 2006, 141(2):191-198.
[13]	Zhu LX, Wang GS, Fan ST. Spontaneous rupture of he-patocellular carcinoma[J]. Br J Surg, 1996, 83(5):602-607.
[14]	Singh Bhinder N, Zangan SM. Hepatocellular carcinoma rupture following transarterial chemoembolization[J]. Semin Intervent Radiol, 2015, 32(1):49-53.
[15]	Zou J, Li C, Chen Y, et al. Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma[J]. Oncol Lett, 2019, 18(6):6423-6430.
[16]	Tu J, Jia Z, Ying X, et al. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma[J]. Medicine (Baltimore), 2016, 95(49):e5606.
[17]	Lee HS, Choi GH, Choi JS, et al. Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea[J]. Ann Surg Treat Res, 2019, 96(6):275-282.
[18]	Rombolà F, Caravetta A, Mollo F, et al. Sorafenib, risk of bleeding and spontaneous rupture of hepatocellular carcinoma. A clinical case[J]. Acta Medica Cordoba, 2011, 54(4):177-179.
[19]	Zhu Q, Li J, Yan JJ, et al. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma[J]. World J Gastroenterol, 2012, 18(48):7302-7307.
[20]	Yang T, Sun YF, Zhang J, et al. Partial hepatectomy for ruptured hepatocellular carcinoma[J]. Br J Surg, 2013, 100(8):1071-1079. doi:10.1002/bjs.9167pmid:23754648
[21]	Wu JJ, Zhu P, Zhang ZG, et al. Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy[J]. Eur J Surg Oncol, 2019, 45(10):1887-1894.
[22]	Yoshida H, Mamada Y, Taniai N, et al. Spontaneous ruptured hepatocellular carcinoma[J]. Hepatol Res, 2015, 46(1):13-21.
[23]	Matsumoto T, Chung H, Suginoshita Y, et al. Outcomes and prognostic factors in patients with spontaneously ruptured hepatocellular carcinoma[J]. Hepatogastroenterology, 2015, 62(140):942-946.
[24]	Leung CS, Tang CN, Fung KH, et al. A retrospective review of transcatheter hepatic arterial embolisation for ruptured hepatocellular carcinoma[J]. J R Coll Surg Edinb, 2002, 47(5):685-688. pmid:12463708
[25]	Aoki T, Kokudo N, Matsuyama Y, et al. Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey[J]. Ann Surg, 2014, 259(3):532-542.
[26]	Pinal-García DF, Nuño-Guzmán CM, Gómez-Abarca A. Spontaneous rupture of hepatocellular carcinoma in a young patient with fatal outcome[J]. Case Rep Gastroenterol, 2018, 12(1):19-26. doi:10.1159/000486193pmid:29515341
[27]	高志慧, 柏斗胜. 精准医学时代肝细胞癌破裂出血的诊治[J]. 外科理论与实践, 2018, 23(3):217-220.
[28]	Zhu Q, Qiao G, Xu C, et al. Conditional survival in patients with spontaneous tumor rupture of hepatocellular carcinoma after partial hepatectomy: a propensity score matching analysis[J]. HPB(Oxford), 2019, 21(6):722-730.
[29]	Mizuno S, Yamagiwa K, Ogawa T, et al. Are the results of surgical treatment of hepatocellular carcinoma poor if the tumor has spontaneously ruptured?[J]. Scand J Gastroenterol, 2004, 39(6):567-570.
[30]	Portolani N, Baiocchi GL, Gheza F, et al. Parietal and peritoneal localizations of hepatocellular carcinoma: Is there a place for a curative surgery?[J]. World J Surg Oncol, 2014, 12:298. doi:10.1186/1477-7819-12-298pmid:25255984
[31]	刘炳琪. 原发性肝癌自发性破裂出血38例临床诊疗分析[D]. 山东大学, 2016.
[32]	Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal[J]. Br J Surg, 2010, 82(1):122-126.
[33]	Sasaki A, Shibata K, Ohta M, et al. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma[J]. Eur J Surg Oncol, 2006, 32(7):773-779.
[34]	Zheng SZ, Liu DJ, Sun P, et al. Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture[J]. World J Gastroenterol, 2014, 20(43):16275-16281.
[35]	Liao Y, Zheng Y, He W, et al. Sorafenib therapy follo-wing resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence[J]. Oncol Lett, 2017, 13(2):984-992.

肝癌破裂出血规范化治疗探讨

Research on standardized treatment of spontaneous rupture of hepatocellular carcinoma

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表1

参考文献35

相关文章15

编辑推荐

Metrics

本文评价

[1]	华鹏a，舒雄鹏a，谢叻a,b.柔性输尿管镜末端偏转运动的迟滞特性建模与运动补偿[J]. J Shanghai Jiaotong Univ Sci, 2023, 28(4): 507-.
[2]	黎定佳1,2,3,4, 王重阳1,2,3, 郭伟5, 王志东6, 张忠涛5, 刘浩1,2,3.基于少量多核光纤光栅传感器的单孔连续体手术机器人形状感知[J]. J Shanghai Jiaotong Univ Sci, 2023, 28(3): 312-322.
[3]	高红岩1, 2，艾孝杰1, 2，孙正隆3，陈卫东1, 2，高安柱1, 2.手术机器人的力感知技术进展[J]. J Shanghai Jiaotong Univ Sci, 2023, 28(3): 370-381.
[4]	江雪　黄莹　杨欣　刁培欣　侯莉　陈萍　丁维. 手术室临床应用场景中无菌物品的数字化信息化管理实践与体会 [J]. 组织工程与重建外科杂志, 2023, 19(3): 285-.
[5]	管亚芩　吴锦阳　余丽雅　张诗雷. 数字化手术设计流程在颌面部骨折整复治疗中的应用分析 [J]. 组织工程与重建外科杂志, 2023, 19(3): 289-.
[6]	武晓莉　班耀林　陈立彬　谢春晖　马倩玉　王文波. “核心剥离式”瘢痕疙瘩修薄术联合放疗的疗效分析 [J]. 组织工程与重建外科杂志, 2023, 19(1): 22-.
[7]	侯森林, 于廷廷, 刘鹏翔, 张立超.超声内镜介入治疗在胆胰疾病中的应用[J]. 外科理论与实践, 2023, 28(04): 300-306.
[8]	张建国.胆囊疾病的内镜处理[J]. 外科理论与实践, 2023, 28(04): 321-325.
[9]	朱巧俐, 苗伊鸣, 陈小松.I~III期三阴性乳腺癌病人接受保乳手术或乳房切除术的预后分析[J]. 外科理论与实践, 2023, 28(04): 371-377.
[10]	杨奕, 杨兴霞, 金思励, 张旭, 朱娟英, 陈小松.术前MRI检查在乳腺导管原位癌保乳手术的临床应用研究[J]. 外科理论与实践, 2023, 28(04): 378-382.
[11]	高攀, 蔡云强, 彭兵.保留功能的腹腔镜胰头部及十二指肠乳头肿瘤切除手术[J]. 外科理论与实践, 2023, 28(03): 190-196.
[12]	王斌, 仇明.腔镜甲状腺外科手术的精细化操作技术[J]. 外科理论与实践, 2023, 28(03): 197-201.
[13]	艾克拜尔·艾力, 玉素江·图荪托合提, 克力木·阿不都热依木.胃食管反流病的微创手术治疗现状[J]. 外科理论与实践, 2023, 28(03): 208-214.
[14]	黄先觉, 姚琪远.微创手术助推肥胖与代谢性疾病的外科治疗[J]. 外科理论与实践, 2023, 28(03): 215-219.
[15]	燕速, 郑民华.中国单孔及减孔腹腔镜胃癌手术实践[J]. 外科理论与实践, 2023, 28(03): 233-239.